chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 38.0
Sex: U
Vaccine: SMALLMNK
Symptoms: Pharyngeal swelling
Clinical narrative: RNs responded to a knock on the door of immunization clinic.  Client was recognized as had received first dose of Jynneos vaccine a few minutes prior. Client verbalized feeling swelling of the throat, was directed into clinic vaccination area chair, Station #1, to sit. Vitals were taken at 10.09 am as RN prepared 1mL diphenhydramine for client administration.  Vitals at 10.09 am 147/88, HR 71. O2 Sat. 99%. Diphenhydramine administered on opposite arm of vaccination, right arm, at 10.11 am.  Client denied difficulty breathing or speaking at the time.  RN called to assist.  Vitals taken again at 5 minutes, 121/72, HR 60, O2 Sat 98%.  10.29 am client verbalized feeling better, denied c/o throat swelling.  10.35 am vitals 119/61, HR 61, 98%.   10.40 am client verbalized needing to go to the restroom, accompanied by RN, gait and symmetry of stride within normal range and no difficult upon standing or sitting.  Client verbalized feeling better and no longer feeling swelling of the throat and wanting to go home.    Client refused further care and left the clinic with no further complaints or concerns, agreed to self-monitor and when to seek medical care if symptoms re-occur.  Client left clinic at 10.45 am.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Pt was given Morderna 6yr -11yr instead of Moderna Bivalent.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: On 9/19/2022 Patient was given 0.5 mL dose of the first shot in the primary MODERNA COVID-19 series, and then it was realized that the lot was expired on 9/10/2022. Director of Nursing at the Health District notified, and this nurse was instructed to contact the manufacturing company, Moderna on 9/20/2022. Moderna gave me a reference case number of MOD22-024062 and said their team would perform a lot assessment that would take 3-5 days to complete that would provide further instruction(s) on how to proceed. Moderna emailed the Director of Nursing with the lot assessment findings on 9/23/2022 and these results were then discussed with Dr. our medical provider and our Health Commissioner on how to proceed. I attempted to contact the patient on 9/26/2022 but they did not answer, so a voicemail was left asking them to call me back. Will continue to attempt at contacting the patient to let them know they were given an expired dose and to tell them how important it is for them to get their second dose for full protection.
Age: 79.0
Sex: F
Vaccine: COVID19-2, COVID19-2
Symptoms: Paralysis, Pyrexia
Clinical narrative: fever, paralysis
Age: 79.0
Sex: F
Vaccine: COVID19-2, COVID19-2
Symptoms: Balance disorder, Urinary tract infection
Clinical narrative: fever, paralysis
Age: 34.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Injection site induration, Injection site warmth
Clinical narrative: Patient went to his primary care office on Monday 9/26/22 and reported a large indurated reaction around the vaccine injection site. Clinic nurse practitioner assessed patient. The site is warm to the touch, but not painful. Does not appear infected. Patient given instructions to return to clinic or ED if symptoms worsen.
Age: 62.0
Sex: F
Vaccine: COVID19-2, COVID19-2
Symptoms: Acute myocardial infarction, Chest discomfort, Electrocardiogram, Supraventricular tachycardia
Clinical narrative: Chest pressure, supraventricular tachycardia with heart rate in 160s and NSTEMI without EKG changes.
Age: 62.0
Sex: F
Vaccine: COVID19-2, COVID19-2
Symptoms: Atrial fibrillation, Cardiac stress test normal, Chest X-ray normal, Computerised tomogram normal, Electrocardiogram abnormal
Clinical narrative: Chest pressure, supraventricular tachycardia with heart rate in 160s and NSTEMI without EKG changes.
Age: 62.0
Sex: F
Vaccine: COVID19-2, COVID19-2
Symptoms: Heart rate increased
Clinical narrative: Chest pressure, supraventricular tachycardia with heart rate in 160s and NSTEMI without EKG changes.
Age: 49.0
Sex: F
Vaccine: COVID19-2
Symptoms: Lip swelling, Swelling face
Clinical narrative: Report of facial swelling the next day after the new bivalent vaccine booster received yesterday.  She went to urgent care today 9/20 later in the morning after going to work because her lips were swollen at first but it moved to more of her whole face.  She took Benadryl at home for the lips and then went to the urgent care where she received a steroid injection in her buttocks and a prescription to take oral steroid to tapper down.  She had no other symptoms and is feeling fine otherwise.  She has not had any history facial fillers or injections.  Doing fine now and waiting for swelling to go down. 9/21/2022 swelling resolved.
Age: 64.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Dizziness, Erythema, Fatigue, Headache
Clinical narrative: Headache started within 15 minutes. Fatigue, flu feelings. 2nd day much worse. Flu feelings, headache, chills, 101 fever. 3rd day headaches on and off, extreme fatigue. Took Tylenol each day. 4th day feel tired and slightly woozy.  Arm swollen 3/4 inch raised up, 3-inch diameter round red mark that is still present on day 4 with soreness.
Age: 64.0
Sex: F
Vaccine: VARZOS
Symptoms: Influenza, Pain, Peripheral swelling, Pyrexia
Clinical narrative: Headache started within 15 minutes. Fatigue, flu feelings. 2nd day much worse. Flu feelings, headache, chills, 101 fever. 3rd day headaches on and off, extreme fatigue. Took Tylenol each day. 4th day feel tired and slightly woozy.  Arm swollen 3/4 inch raised up, 3-inch diameter round red mark that is still present on day 4 with soreness.
Age: 15.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered, Product administered to patient of inappropriate age
Clinical narrative: 15 year old given Moderna bivalent booster. Moderna authorized for 18+ only. Mother notified by vaccinator on site.
Age: 68.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Asthma, Condition aggravated, Cough, Decreased appetite, Nausea
Clinical narrative: Starting the evening after receiving both vaccines, I woke up with a fever. I had it for about 2 to 2.5 days. The highest it went was about 101. I contacted my doctor who told me to take Tylenol and if my fever went above 101 to go to the ER. I did develop a cough a few days after contacting the doctor but I was unsure if related to my asthma or the shot. My asthma was not bothering me prior to the shots but I had to use the rescue inhaler more during that week following the vaccines. Also, I felt nauseated, was vomiting, had no appetite and that went on until last week. This weekend was the first weekend I started getting some of my appetite back and some energy back. I was told to take a COVID test the first time I contacted the doctor (results were negative). She told me to repeat the test in 5 days (which I did and that was negative). She thought it could possibly be a virus going around. She told me to rest, drink lots of fluids and, if any other adverse events arise, to call her.   My first 2 COVID-19 vaccines were J&J. My 1st and 2nd booster were Moderna.
Age: 68.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Pyrexia, SARS-CoV-2 test negative, Vomiting
Clinical narrative: Starting the evening after receiving both vaccines, I woke up with a fever. I had it for about 2 to 2.5 days. The highest it went was about 101. I contacted my doctor who told me to take Tylenol and if my fever went above 101 to go to the ER. I did develop a cough a few days after contacting the doctor but I was unsure if related to my asthma or the shot. My asthma was not bothering me prior to the shots but I had to use the rescue inhaler more during that week following the vaccines. Also, I felt nauseated, was vomiting, had no appetite and that went on until last week. This weekend was the first weekend I started getting some of my appetite back and some energy back. I was told to take a COVID test the first time I contacted the doctor (results were negative). She told me to repeat the test in 5 days (which I did and that was negative). She thought it could possibly be a virus going around. She told me to rest, drink lots of fluids and, if any other adverse events arise, to call her.   My first 2 COVID-19 vaccines were J&J. My 1st and 2nd booster were Moderna.
Age: 2.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: Third dose Pfizer covid 19 vaccine inadvertently given earlier than recommended. No adverse outcomes. Parent will be made aware.
Age: 76.0
Sex: F
Vaccine: FLU4
Symptoms: Injection site pain, Injection site swelling, Pain
Clinical narrative: Site: Pain at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Patient came back in couple of hours after receiving the vaccine and site of injection was swollen. It hurt upon lifting the arm. advised patient on taking ibuprofen. patient refused. pt thinks she will be ok by tomorrow. I will follow up with her tomorro-Medium, Additional Details: I will reach out to patient tomorrow. i recommended ice pack. I apologized. she was very understanding. arms don't tingle. no pain shoulder. just hurts upon touching the injection site. She thinks it's a mild pain. I advised on tylenol if she does not want to take ibuprofen just to help with inflammation. patient did not complain of join pain. this report does not let me go furthur without selecting wrong option
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Itching of the hands and feet
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Rash
Clinical narrative: I had my vaccination on 09/20/2022. On 09/22/2022 I woke up at 4AM and had a rash on the left side of my body on the front and back. I called the mobile urgent care and diagnosed with Shingles. Started on steroids and antiviral medications. I did a consultation with my dermatologist to skip injections until Shingles has resolved.
Age: 54.0
Sex: F
Vaccine: FLUR4
Symptoms: Chills, Cough, Dysphagia, Dysphonia, Immunisation reaction
Clinical narrative: Per pt.,  "I woke up on Wednesday morning with a very ?scratchy? or funny feeling in my throat. I felt fine otherwise. I woke up on Wednesday night with a very sore throat and had a low grade temp of 99.6, muscle aches. I did a Covid test that was negative and came to work as I suspected this was from the flu vaccine. We were too short staffed to call off sick. I continued with achiness all day and by the time my shift ended, I had chills, muscle aches and fever 101.7 by the time I got home.  I continued to wake up at night with a severe sore throat and was difficult to swallow. My temp on Friday was 99.6 and improved by evening.   I went to Urgent care as I was concerned that maybe I had strep. I had a total of 3 negative Covid tests at this point. My strep was negative.  At urgent care, he said my throat was swollen and gave me viscous lidocaine as I could not swallow. At Urgent care, I was told this was most likely from the vaccine and recommended that I speak to my usual specialists.  Urgent care did give me an antibiotic if this did not improve, which I did start ( this was started after my temp was already better).  My temp has improved since Friday evening, and sore throat improved on Saturday, but I continue with some hoarseness and dry cough even today.
Age: 54.0
Sex: F
Vaccine: FLUR4
Symptoms: Myalgia, Oropharyngeal discomfort, Oropharyngeal pain, Pain, Pharyngeal swelling
Clinical narrative: Per pt.,  "I woke up on Wednesday morning with a very ?scratchy? or funny feeling in my throat. I felt fine otherwise. I woke up on Wednesday night with a very sore throat and had a low grade temp of 99.6, muscle aches. I did a Covid test that was negative and came to work as I suspected this was from the flu vaccine. We were too short staffed to call off sick. I continued with achiness all day and by the time my shift ended, I had chills, muscle aches and fever 101.7 by the time I got home.  I continued to wake up at night with a severe sore throat and was difficult to swallow. My temp on Friday was 99.6 and improved by evening.   I went to Urgent care as I was concerned that maybe I had strep. I had a total of 3 negative Covid tests at this point. My strep was negative.  At urgent care, he said my throat was swollen and gave me viscous lidocaine as I could not swallow. At Urgent care, I was told this was most likely from the vaccine and recommended that I speak to my usual specialists.  Urgent care did give me an antibiotic if this did not improve, which I did start ( this was started after my temp was already better).  My temp has improved since Friday evening, and sore throat improved on Saturday, but I continue with some hoarseness and dry cough even today.
Age: 54.0
Sex: F
Vaccine: FLUR4
Symptoms: Pyrexia, SARS-CoV-2 test negative, Streptococcus test negative, Throat irritation
Clinical narrative: Per pt.,  "I woke up on Wednesday morning with a very ?scratchy? or funny feeling in my throat. I felt fine otherwise. I woke up on Wednesday night with a very sore throat and had a low grade temp of 99.6, muscle aches. I did a Covid test that was negative and came to work as I suspected this was from the flu vaccine. We were too short staffed to call off sick. I continued with achiness all day and by the time my shift ended, I had chills, muscle aches and fever 101.7 by the time I got home.  I continued to wake up at night with a severe sore throat and was difficult to swallow. My temp on Friday was 99.6 and improved by evening.   I went to Urgent care as I was concerned that maybe I had strep. I had a total of 3 negative Covid tests at this point. My strep was negative.  At urgent care, he said my throat was swollen and gave me viscous lidocaine as I could not swallow. At Urgent care, I was told this was most likely from the vaccine and recommended that I speak to my usual specialists.  Urgent care did give me an antibiotic if this did not improve, which I did start ( this was started after my temp was already better).  My temp has improved since Friday evening, and sore throat improved on Saturday, but I continue with some hoarseness and dry cough even today.
Age: 13.0
Sex: F
Vaccine: COVID19-2
Symptoms: Syncope
Clinical narrative: Systemic: Fainting / Unresponsive-Mild, Additional Details: informed by her mother that she is scared of vaccines/needles, usually gets dizzy/faints. vaccine was given, patient felt fine, stayed with her for few minutes, informed her to stay in store for 15. after she and her mom walked away, she fainted. she was okay, no other symptoms, called 911, they assessed her, all vitals were normal. patient back to normal.
Age: 40.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Catheter placement, Chest X-ray, Chest tube insertion, Chest tube removal
Clinical narrative: Patient with 3 COVID vaccines who admitted to hospital with COVID detected PCR and complications related to COVID.  Provider d/c note: "41 YO male with a history of T1DM admitted for sepsis secondary to Empyema in the setting of Covid positive infection and DKA.  . Chest CT showed R lung pneumonitis with large pleural effusion and early loculations.  Patient underwent image guided placement of large caliber pigtail catheter and antibiotic treatment with Zosyn.   Hospital Course:    Sepsis 2/2 to right Empyema in the setting of COVID-19, sepsis resolved - Exudative effusion suggested by pleural fluid studies. Continue Zosyn (9/10 - discharge).  Pleural fluid cultures no growth to date. NGTD on cultures.  - S/p chest tube with large caliber pigtail catheter (interventional radiology) on 9/12. Management per CTS. Increased chest tube output since tPA. Daily CXR.  - Scheduled Mobic for pleuritic chest pain - CT abdomen & pelvis w/ oral & IV contrast on day of discharge prior to removal of chest tube - Follow up with CTS in 2 weeks with CXR     Diabetic Ketoacidosis 2/2 infection, resolved Type II Diabetes Mellitus  - HbA1c 10.3 - Hold home oral diabetic medications - 40U nightly Lantus  - 12U prandial insulin - Aggressive Sliding Scale Insulin. - 5g Carb Control Diet - Patient now with good insurance, committed to re-establishing with endocrinology "
Age: 40.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Computerised tomogram abdomen, Computerised tomogram thorax abnormal, Culture negative, Diabetic ketoacidosis, Empyema
Clinical narrative: Patient with 3 COVID vaccines who admitted to hospital with COVID detected PCR and complications related to COVID.  Provider d/c note: "41 YO male with a history of T1DM admitted for sepsis secondary to Empyema in the setting of Covid positive infection and DKA.  . Chest CT showed R lung pneumonitis with large pleural effusion and early loculations.  Patient underwent image guided placement of large caliber pigtail catheter and antibiotic treatment with Zosyn.   Hospital Course:    Sepsis 2/2 to right Empyema in the setting of COVID-19, sepsis resolved - Exudative effusion suggested by pleural fluid studies. Continue Zosyn (9/10 - discharge).  Pleural fluid cultures no growth to date. NGTD on cultures.  - S/p chest tube with large caliber pigtail catheter (interventional radiology) on 9/12. Management per CTS. Increased chest tube output since tPA. Daily CXR.  - Scheduled Mobic for pleuritic chest pain - CT abdomen & pelvis w/ oral & IV contrast on day of discharge prior to removal of chest tube - Follow up with CTS in 2 weeks with CXR     Diabetic Ketoacidosis 2/2 infection, resolved Type II Diabetes Mellitus  - HbA1c 10.3 - Hold home oral diabetic medications - 40U nightly Lantus  - 12U prandial insulin - Aggressive Sliding Scale Insulin. - 5g Carb Control Diet - Patient now with good insurance, committed to re-establishing with endocrinology "
Age: 40.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Glycosylated haemoglobin increased, Pleural effusion, Pleuritic pain, Pneumonitis, SARS-CoV-2 test positive
Clinical narrative: Patient with 3 COVID vaccines who admitted to hospital with COVID detected PCR and complications related to COVID.  Provider d/c note: "41 YO male with a history of T1DM admitted for sepsis secondary to Empyema in the setting of Covid positive infection and DKA.  . Chest CT showed R lung pneumonitis with large pleural effusion and early loculations.  Patient underwent image guided placement of large caliber pigtail catheter and antibiotic treatment with Zosyn.   Hospital Course:    Sepsis 2/2 to right Empyema in the setting of COVID-19, sepsis resolved - Exudative effusion suggested by pleural fluid studies. Continue Zosyn (9/10 - discharge).  Pleural fluid cultures no growth to date. NGTD on cultures.  - S/p chest tube with large caliber pigtail catheter (interventional radiology) on 9/12. Management per CTS. Increased chest tube output since tPA. Daily CXR.  - Scheduled Mobic for pleuritic chest pain - CT abdomen & pelvis w/ oral & IV contrast on day of discharge prior to removal of chest tube - Follow up with CTS in 2 weeks with CXR     Diabetic Ketoacidosis 2/2 infection, resolved Type II Diabetes Mellitus  - HbA1c 10.3 - Hold home oral diabetic medications - 40U nightly Lantus  - 12U prandial insulin - Aggressive Sliding Scale Insulin. - 5g Carb Control Diet - Patient now with good insurance, committed to re-establishing with endocrinology "
Age: 40.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Sepsis
Clinical narrative: Patient with 3 COVID vaccines who admitted to hospital with COVID detected PCR and complications related to COVID.  Provider d/c note: "41 YO male with a history of T1DM admitted for sepsis secondary to Empyema in the setting of Covid positive infection and DKA.  . Chest CT showed R lung pneumonitis with large pleural effusion and early loculations.  Patient underwent image guided placement of large caliber pigtail catheter and antibiotic treatment with Zosyn.   Hospital Course:    Sepsis 2/2 to right Empyema in the setting of COVID-19, sepsis resolved - Exudative effusion suggested by pleural fluid studies. Continue Zosyn (9/10 - discharge).  Pleural fluid cultures no growth to date. NGTD on cultures.  - S/p chest tube with large caliber pigtail catheter (interventional radiology) on 9/12. Management per CTS. Increased chest tube output since tPA. Daily CXR.  - Scheduled Mobic for pleuritic chest pain - CT abdomen & pelvis w/ oral & IV contrast on day of discharge prior to removal of chest tube - Follow up with CTS in 2 weeks with CXR     Diabetic Ketoacidosis 2/2 infection, resolved Type II Diabetes Mellitus  - HbA1c 10.3 - Hold home oral diabetic medications - 40U nightly Lantus  - 12U prandial insulin - Aggressive Sliding Scale Insulin. - 5g Carb Control Diet - Patient now with good insurance, committed to re-establishing with endocrinology "
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Patient vaccinated x3 (02/09/2021, 03/02/2021, 11/05/2021). Patient admitted to hospital 09/22/22 and tested COVID positive 09/23/2022.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Blood test abnormal, Carpal tunnel syndrome, Grip strength decreased, Hypoaesthesia
Clinical narrative: In May of 2022 I was diagnosed with tendonitis and carpal tunnel.  It got progressively worse.  In July 2022 I had numbness in both hands.  I had a nerve study done.  I saw a neurologist and I was diagnosed with permanent nerve loss in three digits.  I still thought it was due to carpal tunnel.  My sports doctor had set up consult with the hand surgeon and neurologist and referred to a rheumatologist.  I saw this doctor in mid-September.  I also have had joint pain.  Unable to cut with a knife, hold a fork or open a bottle.  I began occupational therapy.  As of today, I am feeling better because I have been taking steroid medication as prescribed.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Nerve conduction studies abnormal, Nervous system disorder, Tendonitis, Ultrasound scan abnormal, X-ray abnormal
Clinical narrative: In May of 2022 I was diagnosed with tendonitis and carpal tunnel.  It got progressively worse.  In July 2022 I had numbness in both hands.  I had a nerve study done.  I saw a neurologist and I was diagnosed with permanent nerve loss in three digits.  I still thought it was due to carpal tunnel.  My sports doctor had set up consult with the hand surgeon and neurologist and referred to a rheumatologist.  I saw this doctor in mid-September.  I also have had joint pain.  Unable to cut with a knife, hold a fork or open a bottle.  I began occupational therapy.  As of today, I am feeling better because I have been taking steroid medication as prescribed.
Age: 12.0
Sex: M
Vaccine: MENB
Symptoms: No adverse event, Wrong product administered
Clinical narrative: Gave Meningococcal  B, OMV instead should of give  Meningococcal  Polysaccharide (Groups A, C, Y, W-135)  TT Conjugate.  The Pt did not have any adverse reaction to the Vaccine.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Death, Endotracheal intubation, Influenza like illness
Clinical narrative: pt had a hospital stay 1/23/22 - 2/5/22 for flu-like sx; pt had a positive COVID test; COVID pneumonia; given ABX, IVFs, dexamethasone, remdesivir, O2 supplementation; worsened respiratory status requiring intubation; ICU; eventually able to be extubated and weaned to O2 via NC and then RA; status changed to DNR/DNI and pursue hospice care; did not want PEG tube; dc'd to home where he passed away
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Intensive care, Respiratory disorder, SARS-CoV-2 test positive
Clinical narrative: pt had a hospital stay 1/23/22 - 2/5/22 for flu-like sx; pt had a positive COVID test; COVID pneumonia; given ABX, IVFs, dexamethasone, remdesivir, O2 supplementation; worsened respiratory status requiring intubation; ICU; eventually able to be extubated and weaned to O2 via NC and then RA; status changed to DNR/DNI and pursue hospice care; did not want PEG tube; dc'd to home where he passed away
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Error: Wrong Vaccine Formulation (ex. Prevnar 13 v. Prevnar 23)-
Age: 50.0
Sex: F
Vaccine: FLU4
Symptoms: Expired product administered
Clinical narrative: Pt was given a Flu Shot that exp. on 6-30-22
Age: 27.0
Sex: M
Vaccine: COVID19-2
Symptoms: Underdose
Clinical narrative: On the above-listed date, a vaccination clinic was held for staff to receive the COVID-19 booster vaccination.  On this day we had Bivalent Moderna Booster dosed vials on hand to be given to those requesting the booster dose.  At the time of the clinic, the vaccinator was operating on incorrect information that the Moderna Booster vaccination for the Bivalent vaccine was 0.25 mgs rather than the new dosage of 0.5mgs.  The error was not noticed until the end of the clinic.  Immediately the error was communicated to those affected.  All patients requesting so were vaccinated with the remaining 0.25 mgs within 24 hours in line with the FDA and CDC recommendations for this specific error.  Two patients were contacted but requested the full dosage of the booster vaccine in the coming weeks.  Three patients were contacted and chose not to be vaccinated further.  There were no reactions noted upon follow-up.  All patients were advised to communicate with their primary care doctors and follow up with them should there be any adverse reactions.  The entire department debriefed and confirmed all new information and rehabilitated the draw-up and delivery of SOPS for all vaccinations in the future. This error was taken very seriously and all means of ensuring this is to not happen in the future were implemented.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Blood glucose increased, Blood test, Insulin resistance, Lipids normal
Clinical narrative: The day after receiving my COVID vaccine and Flu shot for over age of 65, I checked my blood sugar levels and noticed it was at 351,. Over the next week the range would be from 250-350. I received a call from a diabetic organization I am affiliated with checking on me because of my high levels. I contacted my physician about this and she was concerned that my glucose numbers were so high, she wanted to put me on another form of control and insulin. I went back a few days later and found that my body is producing plenty of insulin, but my cells had become insulin resistant. After a full week, my numbers returned to normal.
Age: 84.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acute respiratory failure, COVID-19, Chest pain, Death, Dyspnoea
Clinical narrative: "Patient with 3 COVID vaccines who admitted to hospital with COVID detected PCR and complications of COVID who subsequently died of COVID complications.  Hospice provider consult note (patient died prior to admission to hospice):  ""86 YO female with a past medical history of mild chronic obstructive pulmonary disease, prior lung cancer status post LUL resection, scleroderma, Sjogren's syndrome.  Followed with Dr. outpatient.  Presented with fever, dyspnea and chest pain and admitted with diagnosis of COVID-19 and acute hypoxic respiratory failure.  She continued worsening inpatient with increased oxygen requirement.   Care service is now asked to see the patient for goals of care.     At time of initial consult she is on high-flow nasal cannula oxygen 40 liters/minute at 90%.  Per family report she is much more greatly fatigued today than previously.  She has asked several family members to just let me go and I do not want to do this anymore.    IMPRESSIONS / PLAN:   Care Issues: Conversion to comfort directed end of life care   1. Medical decision making capacity:  At the time of our consult the patient has limited ability for participation and medical decision making due to being in extremis.  Recent history of encephalopathy over past few days.  Neurology had evaluated as multifactorial metabolic encephalopathy. There are documents. Medical power of attorney 1.  Is husband 2. Is daughter   2. Goals of Care:  medical team had several meetings with family members today.  First meeting today involved daughter,  with myself and medical care chaplain. We shared some of the prognostic information from consultants and primary medical team.  Shared likely end of life trajectory given her acute on chronic respiratory failure.  Shared the ethics of decision making involving the patient's previously expressed personal wishes, including stating that she wanted to stop with aggressive care.  Discussed a reasonable plan for symptom management and the burdens and benefits of symptom management at end of life, including down and off titration of high-flow nasal cannula oxygen.  Another meeting was held this afternoon with myself, again daughter, and brothers.  The patient's husband, is present however he prefers to stay at the wife's bedside.   Comfort-directed End of Life care   3. Code Status:  No CPR/DNI/comfort 4. Psychosocial and Spiritual Support: Chaplain was present at family meeting today and religious priest was called by hospital chaplain this afternoon 5. medical care follow up :  medical Care will help to place comfort care orders.   Also placed hospice referral order and asking liaison to get hospice consent signed.  We can begin the process of admitting.  Family has already agreed to that plan.
Age: 84.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Fatigue, Metabolic encephalopathy, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: "Patient with 3 COVID vaccines who admitted to hospital with COVID detected PCR and complications of COVID who subsequently died of COVID complications.  Hospice provider consult note (patient died prior to admission to hospice):  ""86 YO female with a past medical history of mild chronic obstructive pulmonary disease, prior lung cancer status post LUL resection, scleroderma, Sjogren's syndrome.  Followed with Dr. outpatient.  Presented with fever, dyspnea and chest pain and admitted with diagnosis of COVID-19 and acute hypoxic respiratory failure.  She continued worsening inpatient with increased oxygen requirement.   Care service is now asked to see the patient for goals of care.     At time of initial consult she is on high-flow nasal cannula oxygen 40 liters/minute at 90%.  Per family report she is much more greatly fatigued today than previously.  She has asked several family members to just let me go and I do not want to do this anymore.    IMPRESSIONS / PLAN:   Care Issues: Conversion to comfort directed end of life care   1. Medical decision making capacity:  At the time of our consult the patient has limited ability for participation and medical decision making due to being in extremis.  Recent history of encephalopathy over past few days.  Neurology had evaluated as multifactorial metabolic encephalopathy. There are documents. Medical power of attorney 1.  Is husband 2. Is daughter   2. Goals of Care:  medical team had several meetings with family members today.  First meeting today involved daughter,  with myself and medical care chaplain. We shared some of the prognostic information from consultants and primary medical team.  Shared likely end of life trajectory given her acute on chronic respiratory failure.  Shared the ethics of decision making involving the patient's previously expressed personal wishes, including stating that she wanted to stop with aggressive care.  Discussed a reasonable plan for symptom management and the burdens and benefits of symptom management at end of life, including down and off titration of high-flow nasal cannula oxygen.  Another meeting was held this afternoon with myself, again daughter, and brothers.  The patient's husband, is present however he prefers to stay at the wife's bedside.   Comfort-directed End of Life care   3. Code Status:  No CPR/DNI/comfort 4. Psychosocial and Spiritual Support: Chaplain was present at family meeting today and religious priest was called by hospital chaplain this afternoon 5. medical care follow up :  medical Care will help to place comfort care orders.   Also placed hospice referral order and asking liaison to get hospice consent signed.  We can begin the process of admitting.  Family has already agreed to that plan.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Error: Wrong Vaccine Formulation (ex. Prevnar 13 v. Prevnar 23)-
Age: 34.0
Sex: F
Vaccine: FLU4
Symptoms: Expired product administered
Clinical narrative: Pt was given a Flu Shot that exp. on 06-30-1-22
Age: 37.0
Sex: M
Vaccine: COVID19-2
Symptoms: Underdose
Clinical narrative: On the above-listed date, a vaccination clinic was held for staff to receive the COVID-19 booster vaccination.  On this day we had Bivalent Moderna Booster dosed vials on hand to be given to those requesting the booster dose.  At the time of the clinic, the vaccinator was operating on incorrect information that the Moderna Booster vaccination for the Bivalent vaccine was 0.25 mls rather than the new dosage of 0.5mls.  The error was not noticed until the end of the clinic.  Immediately the error was communicated to those affected.  All patients requesting so were vaccinated with the remaining 0.25 mls within 24 hours in line with the FDA and CDC recommendations for this specific error.  Two patients were contacted but requested the full dosage of the booster vaccine in the coming weeks.  Three patients were contacted and chose not to be vaccinated further.  There were no reactions noted upon follow-up.  All patients were advised to communicate with their primary care doctors and follow up with them should there be any adverse reactions.  The entire department debriefed and confirmed all new information and rehabilitated the draw-up and delivery of SOPS for all vaccinations in the future. This error was taken very seriously and all means of ensuring this is to not happen in the future were implemented.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Atelectasis, COVID-19, Chest X-ray abnormal, Clostridium test positive, Diarrhoea
Clinical narrative: Patient presented to ER from facility with reported SOB, fever and recent diagnosis of COVID19. Evaluation noting tachypnea, tachycardia and fever. Work up noting leukocytosis, elevated PCT. CXR completed noting interstitial markings in bilateral lower lung fields with basilar atelectasis. Later became hypotensive requiring IVF therefore admitted for further evaluation and management.    Patient developed diarrhea and tested positive for c diff. ID consulted and patient initiated on oral vancomycin. Additionally, IV remdesevir added for COVID19 infection.     Patient remains stable without hypoxia, received IV remdesevir x 5 days
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Hypotension, Interstitial lung disease, Leukocytosis, Procalcitonin increased
Clinical narrative: Patient presented to ER from facility with reported SOB, fever and recent diagnosis of COVID19. Evaluation noting tachypnea, tachycardia and fever. Work up noting leukocytosis, elevated PCT. CXR completed noting interstitial markings in bilateral lower lung fields with basilar atelectasis. Later became hypotensive requiring IVF therefore admitted for further evaluation and management.    Patient developed diarrhea and tested positive for c diff. ID consulted and patient initiated on oral vancomycin. Additionally, IV remdesevir added for COVID19 infection.     Patient remains stable without hypoxia, received IV remdesevir x 5 days
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test positive, Tachycardia, Tachypnoea
Clinical narrative: Patient presented to ER from facility with reported SOB, fever and recent diagnosis of COVID19. Evaluation noting tachypnea, tachycardia and fever. Work up noting leukocytosis, elevated PCT. CXR completed noting interstitial markings in bilateral lower lung fields with basilar atelectasis. Later became hypotensive requiring IVF therefore admitted for further evaluation and management.    Patient developed diarrhea and tested positive for c diff. ID consulted and patient initiated on oral vancomycin. Additionally, IV remdesevir added for COVID19 infection.     Patient remains stable without hypoxia, received IV remdesevir x 5 days
Age: 68.0
Sex: M
Vaccine: FLU4
Symptoms: Product storage error
Clinical narrative: Systemic: no reaction-Mild, Additional Details: Vaccine stored out of range
Age: 11.0
Sex: F
Vaccine: HPV9
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: No adverse events noted,  Vaccine was administered to early on 08/25/2022, Guardian notified and follow up per next office visit on 09/14/2022 no adverse reaction or concerns stated per Guardian.
Age: 17.0
Sex: F
Vaccine: FLU4, MENB
Symptoms: Nausea, Pyrexia, Syncope
Clinical narrative: Had vaccines in the late afternoon, then played soccer with her team. On the drive home, she felt nauseous and fainted. She was able to pull over before fainting. Continued to feel nauseous with low grade fever the next day. Rested and felt better the next day.
Age: 29.0
Sex: F
Vaccine: COVID19-2
Symptoms: Chills, Dizziness
Clinical narrative: Systemic: Chills-Mild, Systemic: Dizziness / Lightheadness-Medium
Age: 61.0
Sex: F
Vaccine: COVID19-2
Symptoms: Underdose
Clinical narrative: On the above-listed date, a vaccination clinic was held for staff to receive the COVID-19 booster vaccination. On this day we had Bivalent Moderna Booster dosed vials on hand to be given to those requesting the booster dose.  At the time of the clinic, the vaccinator was operating on incorrect information that the Moderna Booster vaccination for the Bivalent vaccine was 0.25 mls rather than the new dosage of 0.5mls.  The error was not noticed until the end of the clinic.  Immediately the error was communicated to those affected.  All patients requesting so were vaccinated with the remaining 0.25 mls within 24 hours in line with the FDA and CDC recommendations for this specific error.  Two patients were contacted but requested the full dosage of the booster vaccine in the coming weeks.  Three patients were contacted and chose not to be vaccinated further.  There were no reactions noted upon follow-up.  All patients were advised to communicate with their primary care doctors and follow up with them should there be any adverse reactions.  The entire department debriefed and confirmed all new information and rehabilitated the draw-up and delivery of or all vaccinations in the future. This error was taken very seriously and all means of ensuring this is to not happen in the future were implemented.
Age: 88.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acute kidney injury, COVID-19, COVID-19 pneumonia, Haematuria, Hyperkalaemia
Clinical narrative: Patient with 3 COVID vaccines who admitted to hospital with COVID detected PCR and complications r/t COVID.  Provider d/c note:  "Summary of Hospitalization: 89-year-old female with past medical history of COPD, chronic pain on chronic opiates, CKD 3, dementia, hypothyroid, and PVD.  Patient was admitted 09/16 for COVID-19 pneumonia after presenting with symptoms of altered mental status which dramatically improved prior to discharge per granddaughter .  This may be related to decreasing gabapentin versus treating her hypoxia/COVID.  Patient was hypoxic on presentation requiring supplemental O2.  She has been started remdesivir and Decadron at and completed 5 days remdesivir prior to discharge.  She was weaned off oxygen 24 hours prior to discharge.  She may have some chronic hypoxia as her primary care physician had prescribed in the past but she was not compliant with it.  She had a mild AKI and hyperkalemia which resolved.  She did have some hematuria I would recommend repeating UA as outpatient."
Age: 88.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Hypoxia, Mental status changes, SARS-CoV-2 test positive, Urine analysis abnormal
Clinical narrative: Patient with 3 COVID vaccines who admitted to hospital with COVID detected PCR and complications r/t COVID.  Provider d/c note:  "Summary of Hospitalization: 89-year-old female with past medical history of COPD, chronic pain on chronic opiates, CKD 3, dementia, hypothyroid, and PVD.  Patient was admitted 09/16 for COVID-19 pneumonia after presenting with symptoms of altered mental status which dramatically improved prior to discharge per granddaughter .  This may be related to decreasing gabapentin versus treating her hypoxia/COVID.  Patient was hypoxic on presentation requiring supplemental O2.  She has been started remdesivir and Decadron at and completed 5 days remdesivir prior to discharge.  She was weaned off oxygen 24 hours prior to discharge.  She may have some chronic hypoxia as her primary care physician had prescribed in the past but she was not compliant with it.  She had a mild AKI and hyperkalemia which resolved.  She did have some hematuria I would recommend repeating UA as outpatient."
Age: 71.0
Sex: M
Vaccine: COVID19-2
Symptoms: Condition aggravated, Diverticulitis
Clinical narrative: Flare-up of my preexisting, intemittent  divertiulitis Augmintin 2x/day for 9 days Ongoing
Age: 39.0
Sex: F
Vaccine: COVID19-2
Symptoms: Arthralgia, Joint stiffness
Clinical narrative: patient reporting arm stiffness and soreness in joint , potentially due to too high of vaccine site
Age: 30.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: Pt. came in and had Moderna dose in from on 3/17/22 and her COVID card that had another dose documented 4/14/22,  administered bivalent booster due to 2 documented doses. Was called today to clarify because pt. stated she has only had one dose. They called and they stated the only dose given was on 3/17/22. Pt was educated over the phone that we were under the impression she had 2 doses, due to error she verbalized understanding. Informed she will need to be revaccinated, states she will come in on Monday
Age: 6.0
Sex: M
Vaccine: FLUC4
Symptoms: Product storage error
Clinical narrative: Systemic: Vaccine stored out of range-Mild, Additional Details: Vaccine stored out of range
Age: 62.0
Sex: M
Vaccine: COVID19-2
Symptoms: Underdose
Clinical narrative: On the above-listed date, a vaccination clinic was held for staff to receive the COVID-19 booster vaccination.  On this day we had Bivalent Moderna Booster dosed vials on hand to be given to those requesting the booster dose.  At the time of the clinic, the vaccinator was operating on incorrect information that the Moderna Booster vaccination for the Bivalent vaccine was 0.25 mls rather than the new dosage of 0.5mls.  The error was not noticed until the end of the clinic.  Immediately the error was communicated to those affected.  All patients requesting so were vaccinated with the remaining 0.25 mls within 24 hours in line with the FDA and CDC recommendations for this specific error.  Two patients were contacted but requested the full dosage of the booster vaccine in the coming weeks.  Three patients were contacted and chose not to be vaccinated further.  There were no reactions noted upon follow-up.  All patients were advised to communicate with their primary care doctors and follow up with them should there be any adverse reactions.  The entire department debriefed and confirmed all new information and rehabilitated the draw-up and delivery of SOPS for all vaccinations in the future. This error was taken very seriously and all means of ensuring this is to not happen in the future were implemented.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: no symptoms or reactions-not given approved Moderna Bivalent Booster
Age: 18.0
Sex: U
Vaccine: COVID19-2
Symptoms: Syncope, Unresponsive to stimuli
Clinical narrative: Systemic: Fainting / Unresponsive-Mild, Additional Details: Patient lied down on floor and was unresponsive for 5-10 seconds. Pt reports this commonly happens to her after a vaccine.
Age: 47.0
Sex: F
Vaccine: COVID19-2
Symptoms: Underdose
Clinical narrative: On the above-listed date, a vaccination clinic was held for staff to receive the COVID-19 booster vaccination.  On this day we had Bivalent Moderna Booster dosed vials on hand to be given to those requesting the booster dose.  At the time of the clinic, the vaccinator was operating on incorrect information that the Moderna Booster vaccination for the Bivalent vaccine was 0.25 mls rather than the new dosage of 0.5mls.  The error was not noticed until the end of the clinic.  Immediately the error was communicated to those affected.  All patients requesting so were vaccinated with the remaining 0.25 mls within 24 hours in line with the FDA and CDC recommendations for this specific error.  Two patients were contacted but requested the full dosage of the booster vaccine in the coming weeks.  Three patients were contacted and chose not to be vaccinated further.  There were no reactions noted upon follow-up.  All patients were advised to communicate with their primary care doctors and follow up with them should there be any adverse reactions.  The entire department debriefed and confirmed all new information and rehabilitated the draw-up and delivery of SOPS for all vaccinations in the future. This error was taken very seriously and all means of ensuring this is to not happen in the future were implemented.
Age: 32.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Malaise
Clinical narrative: Contracted COVID-19 with symptoms >10 days
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Death, Parkinson's disease, SARS-CoV-2 test positive
Clinical narrative: PFIZER COVID VACCINE #3 GIVEN 9/29/21, LOT #301558A; pt in SNF, for severe end-stage Parkinson's disease; positive for COVID test on 1/31/22; dx with COVID pneumonia; pt status DNR-C; MD has been signing off on pt in the facility; transitioned to hospice; pt passed away in the facility on hospice
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Error: Wrong Vaccine Formulation (ex. Prevnar 13 v. Prevnar 23)-
Age: 73.0
Sex: F
Vaccine: COVID19-2
Symptoms: Underdose
Clinical narrative: On the above-listed date, a vaccination clinic was held for staff to receive the COVID-19 booster vaccination.  On this day we had Bivalent Moderna Booster dosed vials on hand to be given to those requesting the booster dose.  At the time of the clinic, the vaccinator was operating on incorrect information that the Moderna Booster vaccination for the Bivalent vaccine was 0.25 mls rather than the new dosage of 0.5mls.  The error was not noticed until the end of the clinic.  Immediately the error was communicated to those affected.  All patients requesting so were vaccinated with the remaining 0.25 mls within 24 hours in line with the FDA and CDC recommendations for this specific error.  Two patients were contacted but requested the full dosage of the booster vaccine in the coming weeks.  Three patients were contacted and chose not to be vaccinated further.  There were no reactions noted upon follow-up.  All patients were advised to communicate with their primary care doctors and follow up with them should there be any adverse reactions.  The entire department debriefed and confirmed all new information and rehabilitated the draw-up and delivery  for all vaccinations in the future. This error was taken very seriously and all means of ensuring this is to not happen in the future were implemented.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Atrial fibrillation, Atrial flutter, Cardiac pacemaker insertion, Colonoscopy abnormal, Condition aggravated
Clinical narrative: I was going to my heart Doctor for a normal check in and was diagnosed with AFIB which was new since having had my COVID-19 Vaccine. I have had to change medications and also was diagnosed with AFLUTTER as well with my heart. I had a pace maker put in in June of 2021.  In February of 2022 I had woken up with what I thought was just terrible diarrhea but due to a medication I was bleeding internally and was passing out my wife had to call emergency number and I was taken to the ER and in the hospital.  I had been experiencing great fatigue but that was really the only thing  I was experiencing symptom wise.  I have since had a  permanent heart implant put in May of 202 because of that intestinal bleed. I have also had my migraine medication and Botox shots stop working for my migraines and have to change my medications and shots to manage them. The fatigue is really what has lasted and I am wobbly and dizzy.